Search for: "Ortho-McNeil Pharmaceutical, Inc. " Results 101 - 120 of 169
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Sep 2010, 12:42 am by admin
TRADEMARK NOTICE: “Levaquin” is a trademark of Johnson & Johnson, Ortho-McNeil Pharmaceutical, Inc., and Johnson & Johnson Pharmaceutical Research & Development. [read post]
14 Feb 2012, 11:50 am by Michelle Yeary
  Or, if knowing the largest pharmaceutical MDL to date is something you can use as an ice breaker. [read post]
22 Jul 2009, 6:05 am
(PatLit) Levaquin (Levofloxacin) – US: CAFC awards only partial costs where depositions used in multiple cases from different district courts: Ortho-McNeil Pharmaceutical, Inc. v. [read post]
22 Aug 2009, 11:03 pm
MANUFACTURER: Johnson & Johnson's Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]
13 Sep 2012, 6:48 pm
Johnson & Johnson’s Ortho-McNeil-Janssen Pharmaceuticals, Inc. has been the defendant in numerous Levaquin injury lawsuits over has tendon ruptures and permanent tendon damage. [read post]
13 Sep 2012, 6:48 pm
Johnson & Johnson’s Ortho-McNeil-Janssen Pharmaceuticals, Inc. has been the defendant in numerous Levaquin injury lawsuits over has tendon ruptures and permanent tendon damage. [read post]
8 Sep 2011, 12:00 pm by Bexis
Ortho-McNeil Pharmaceutical, Inc., 2011 WL 3566855 (N.D. [read post]
2 Jun 2011, 12:46 pm by Bexis
Ortho Pharmaceutical Corp., 681 P.2d 1038, 1052 (Kan. 1984). [read post]
23 Apr 2010, 8:20 am by Press Releases
” Expected to attend are IP leaders from BP America Inc., Merck & Co., Inc., Bose, Brigham Young University, Cornell University, Stanford University, Duke University, Georgetown University, GlaxoSmithKline, Honeywell, Harvard University, Johnson & Johnson, Kauffman Foundation, Lockheed Martin, Massachusetts Institute of Technology (MIT), Mayo Clinic, Ortho-McNeil Pharmaceuticals Inc., Rutgers, Syngenta Biotechnology, Scripps… [read post]
10 Jun 2009, 10:00 pm
Ortho-McNeil Pharmaceutical, 2007 WL 121149, at *4 (S.D. [read post]
25 Aug 2011, 8:14 am by Lawrence B. Ebert
Ortho-McNeil, 520 F.3d at 1364-65 (“[A] flexible TSM test remains the primary guarantor against a non-statutory hindsight analysis . . . . [read post]
25 Aug 2011, 8:14 am by Lawrence B. Ebert
Bayer Schering, 575 F.3d at 1347 (citing O’Farrell, 853 F.2d at 903); see also Ortho-McNeil, 520 F.3d at 1364 (stating the number of options must be “small or easily traversed”). [read post]